BRUKER CORPORATION (BRKR) Gross Margin
- Gross margin · 12 months: Value 46.42%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 46.42% | Gross profit / revenue. Period ending 2026-06-30. $1.62B ÷ $3.50B × 100 ≈ 46.42% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 1.62B USD | Gross Profit |
| Revenue | 3.50B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $1.62B | $3.50B | (m) | 46.42% |
| 2026-03-31 | $1.57B | $3.46B | (m) | 45.29% |
| 2025-12-31 | $1.58B | $3.44B | (m) | 45.91% |
| 2025-09-30 | $1.62B | $3.44B | (m) | 47.16% |
| 2025-06-30 | $1.66B | $3.44B | (m) | 48.25% |
| 2025-03-31 | $1.69B | $3.45B | (m) | 48.98% |
| 2024-12-31 | $1.65B | $3.37B | (m) | 49.00% |
| 2024-09-30 | $1.59B | $3.24B | (m) | 48.95% |
| 2024-06-30 | $1.55B | $3.12B | (m) | 49.70% |
| 2024-03-31 | $1.51B | $3.00B | (m) | 50.20% |
| 2023-12-31 | $1.51B | $2.96B | (m) | 51.05% |
| 2023-09-30 | $1.45B | $2.82B | (m) | 51.41% |
| 2023-06-30 | $1.40B | $2.71B | (m) | 51.63% |
| 2023-03-31 | $1.36B | $2.62B | (m) | 51.85% |
| 2022-12-31 | $1.31B | $2.53B | (m) | 51.59% |
| 2022-09-30 | $1.28B | $2.51B | (m) | 51.14% |
| 2022-06-30 | $1.25B | $2.48B | (m) | 50.68% |
| 2022-03-31 | $1.24B | $2.46B | (m) | 50.33% |
| 2021-12-31 | $1.21B | $2.42B | (m) | 50.03% |
| 2021-09-30 | $1.18B | $2.36B | (m) | 50.00% |
| 2021-06-30 | $1.12B | $2.26B | (m) | 49.49% |
| 2021-03-31 | $1.03B | $2.12B | (m) | 48.45% |
| 2020-12-31 | $939.80M | $1.99B | (m) | 47.29% |
| 2020-09-30 | $923.10M | $1.96B | (m) | 47.10% |
| 2020-06-30 | $928.70M | $1.97B | (m) | 47.15% |
| 2020-03-31 | $972.90M | $2.04B | (m) | 47.80% |
| 2019-12-31 | $995.30M | $2.07B | (m) | 48.02% |
| 2019-09-30 | $971.80M | $2.03B | (m) | 47.96% |
| 2019-06-30 | $940.50M | $1.97B | (m) | 47.70% |
| 2019-03-31 | $915.30M | $1.93B | (m) | 47.54% |
| 2018-12-31 | $900.00M | $1.90B | (m) | 47.48% |
| 2018-09-30 | $880.40M | $1.87B | (m) | 47.02% |
| 2018-06-30 | $856.70M | $1.84B | (m) | 46.52% |
| 2018-03-31 | $836.00M | $1.81B | (m) | 46.12% |
| 2017-12-31 | $813.00M | $1.77B | (m) | 46.04% |
| 2017-09-30 | $778.20M | $1.71B | (m) | 45.62% |
| 2017-06-30 | $765.40M | $1.66B | (m) | 46.00% |
| 2017-03-31 | $752.10M | $1.62B | (m) | 46.40% |
| 2016-12-31 | $742.50M | $1.61B | (m) | 46.08% |
| 2016-09-30 | $733.60M | $1.62B | (m) | 45.31% |
| 2016-06-30 | $715.90M | $1.62B | (m) | 44.15% |
| 2016-03-31 | $715.20M | $1.65B | (m) | 43.46% |
| 2015-12-31 | $708.60M | $1.62B | (m) | 43.64% |
| 2015-09-30 | $712.90M | $1.65B | (m) | 43.11% |
| 2015-06-30 | $712.70M | $1.68B | (m) | 42.49% |
| 2015-03-31 | $743.80M | $1.74B | (m) | 42.78% |
| 2014-12-31 | $763.30M | $1.81B | (m) | 42.20% |
| 2014-09-30 | $783.40M | $1.85B | (m) | 42.28% |
| 2014-06-30 | $809.30M | $1.87B | (m) | 43.23% |
| 2014-03-31 | $810.40M | $1.87B | (m) | 43.34% |
| 2013-12-31 | $805.20M | $1.84B | (m) | 43.78% |
| 2013-09-30 | $813.00M | $1.80B | (m) | 45.05% |
| 2013-06-30 | $828.90M | $1.81B | (m) | 45.71% |
| 2013-03-31 | $815.50M | $1.78B | (m) | 45.84% |
| 2012-12-31 | $831.40M | $1.79B | (m) | 46.41% |
| 2012-09-30 | $806.90M | $1.75B | (m) | 46.13% |
| 2012-06-30 | $785.70M | $1.72B | (m) | 45.69% |
| 2012-03-31 | $781.10M | $1.70B | (m) | 45.94% |
| 2011-12-31 | $752.50M | $1.65B | (m) | 45.56% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $604.00M | $1.30B | (m) | 46.29% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $517.50M | $1.11B | (m) | 46.43% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |